Moderna, Pfizer Test mRNA Experimental Biologics on Children
On Dec. 10, 2020, American biotechnology company Moderna, Inc., which is pioneering the development of experimental messenger RNA (mRNA) therapeutics and vaccines, gave a 12-year old a dose of the company’s mRNA-1273 vaccine in a Phase 2/3 study of the new vaccine. Moderna CEO Stephane Bancel said, “Our goal is to generate data in the […]
FDA Opposes COVID-19 Vaccination Dose and Schedule Changes to Vaccinate More People
Only two weeks after the first experimental biologic for SARS-CoV-2 became available, the U.S. was more than 16 millions doses behind Operation Warp Speed’s goal of giving COVID-19 vaccines to 20 million people by the end of 2020.1 Responding to the slow rollout, Operation Warp Speed chief adviser Moncef Slaoui, MD proposed giving half-doses to […]
Severe Allergic Reactions Reported After Pfizer/BioNTech COVID-19 Vaccinations
Last week the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) issued a strong warning to those who have a history of significant allergic reactions to medicines, foods or vaccines or who carry an epi-pen that they may be at increased individual risk for suffering a serious allergic reaction after receiving the Pfizer/BioNTech COVID-19 […]
Pfizer, Moderna COVID-19 Vaccines Produce ‘Significantly Noticeable’ Side Effects
The chief scientist for the U.S. government’s Operation Warp Speed (OWS) program aimed at facilitating development of COVID-19 vaccines confirmed on Dec. 1, 2020 that 10-15 percent of the volunteers, who participated in clinical trials to test the safety and effectiveness of experimental vaccines developed by Pfizer, Inc. (in partnership with BioNTech SE) and Moderna, […]
Moderna’s COVID-19 Vaccine Provokes ‘COVID-Like Symptoms’ in Phase 3 Trial
Biotechnology firm Moderna, Inc. of Cambridge, Massachusetts began a Phase 3 human clinical trial to test the safety and efficacy of its experimental mRNA-1273 COVID-19 vaccine on July 27, 2020. The randomized, placebo-controlled trial involves giving two 100-microgram doses of the vaccine to 28,618 volunteer participants over 18 years of age, including some elderly people […]
